ESC 2005 - Slides

07/09/2005 00:00:00

Slides resources from ESC Congress 2005

Title	Authors	Session Number
A randomised comparison of dual versus triple antiplatelet therapy	Rasoul	FP2581
Acute coronary syndromes	Hasin	FP935
Acute Myocardial Infarction Prehospital	Nordrehaug	FP88
Air pollution and cardiovascular diseases	Nemmar	FP2067
Are We Managing Prosthetic Valve Endocarditis Correctly ?	Otto	FP3649
Arrhythmias	Vardas	FP936
ASCOT-BPLA: Discussant	Yusuf	FP754
ASSENT-4 PCI - Discussant	Wijns	FP2579
Atrial fibrillation	Crijns	FP123
BASKET - Discussant	Widimsky	FP2577
BASKET: BAsel Stent Kosten-Effektivitats Trial	Pfisterer	FP2576
Cardiac Insufficiency Bisoprolol (CIBIS) III trial	Willenheimer	FP126
CArdiac REsynchronisation in Heart Failure Extension	Swedberg	FP3683
Cardiovascular Disease Prevention in Women	De-Backer	FP2570
Cardiovascular research in Europe post 1/5/04	Williams	FP1476
Cardiovascular research in Europe: a history of success	Luscher	FP1474
Changing patterns and consequences of obesity	Sans-Menendez	FP1928
Characteristics of patients with acute coronary syndromes and unrecognised postprandial hyperglycaemia	Bartnik	FP3827
CIBIS III : What have we learned?	Dickstein	FP127
Combined antiplatelet therapy	Simoons	FP94
COMMENTARY on the ESSENTIAL trial	Nieminen	FP125
congress-docs
Defibrillation in the community Anno 2005	Bossaert	FP1297
Determinants of Antithrombotic Treatment	Crijns	FP1923
Determinants of hospital mortality in acute heart failure in clinical practice	Filippatos	FP2545
Determinants of Rhythm control in paroxysmal fibrillation	Capucci	FP1924
Diabetes and the heart	Dotevall	FP121
Diabetes as a risk factor for Alzheimer’s dementia	Crepaldi	FP2730
Diabetes mellitus: an unrecognised condition in patients with acute myocardial infarction	Cottin	FP1298
Diagnosis of cryptogenic strokes	Amarenco	FP2071
Diet and Nutrition in the Americas	Smith	FP1926
ENDEAVOR I and II Clinical Program	Wijns	FP759
ESC-Congress-HotLines-and-CTU-Reports-2005.pdf
ESC-Congress-Reports-2005.pdf
Estimating cardiovascular risk in women	Njolstad	FP2567
Gender Bias in Research	Lenzen	FP273
Glucose regulation in coronary artery disease - prognostic information from the Euro Heart Survey on Diabetes and the Heart	Simoons	FP1893
Guidelines For Percutaneous Coronary Interventions	Silber	FP786
Guidelines in chronic heart failure	Swedberg	FP2538
Guidelines in chronic heart failure	Swedberg	FP787
Heart Failure and Cardiomyopathies	Ponikowski	FP3695
How and when statins?	Cobbe	FP96
IMAGINE - Discussant	Bertrand	1331
Implications for subsequent diabetes and cardiovascular outcomes	Balkau	FP750
Interaction between APOE genotype and cardiovascular	Fratiglioni	2729
Interventional Cardiology	De-Bruyne	FP3693
Is there a need for non-cardiac lead or non-lead ICD devices!	Daubert	FP3685
Is there any room left for hormone therapy?	Schenck-Gustafsson	2568
ISSUE II - Discussant	Blanc	FP1329
ISSUE II: The Implantable Loop Recorder	Brignole	FP1328
JUPITER II : double blind randomized comparison	Morice	FP2572
JUPITER II : double blind randomized comparison with the Tecnic Carbostent	Serruys	FP2573
Lifestyle and dietary interventions	Eckel	FP751
Management acute heart failure	Nieminen	FP784
Management of non-STE-ACS in 2004	Danchin	FP1326
Mechanisms of plaque instability	Bauters	FP1896
MR Impact	Schwitter	FP3680
Myocardial infarction criteria following coronary angioplasty or surgery. Time for reassessment?	Antman	FP791
Myocardial Infarction Criteria Following PCI or Surgery	Hamm	FP790
Myocardial Infarction: Refinements in the Criteria for Cardiac Markers	Jaffe	FP788
Non-pharmacological management of acute heart failure	Rozenman	FP3655
NORVIT - Discussant	Graham	FP1335
Novel biomarkers	De Lemos	FP92
Patent foramen ovale closure for cryptogenic stroke	Eeckhout	FP2072
Patho - Biology of Asymptomatic Atherosclerosis	Fuster	FP1897
Patients with abnormal glucoseregulation (AGR) and CAD	Standl	FP1895
Percutaneous Coronary Intervention	Sabatine	FP755
Populations with acute coronary syndrome in Europe 2004	Battler	FP1327
PREAMI: Discussant	Danchin	FP129
Presentation of acute heart failure in clinical practice 2005	Nieminen	FP2542
Prevalence and diagnosis of abnormal glucose regulation in patients with coronary artery disease	Bartnik	FP1892
Prophylaxis of endocarditis in patients with prosthetic valves	Hoen	FP3648
Reassessment of ST-segment and Q wave Myocardial	Clemmensen	FP789
Renal artery stenosis: Therapeutic Strategy	Radermacher	FP1472
Reperfusion therapy for STE-ACS in 2004	Van-De-Werf	FP1324
Results of the Euro Heart Survey Programme	Niemenen	FP120
RITA-3: Discussant	Verheugt	FP89
Role of non-invasive imaging modalities	Rademakers	FP93
S-ICD: A prospective, randomised comparison in humans of defibrillation efficacy	Grace	FP3684
SIRIUS II	Mitrovic	FP132
SOFA - Discussant	Tavazzi-	FP1337
Surgical options with an infected prosthesis - what we say versus what we do	Antunes	FP3651
Symptomatic or asymptomatic atrial fibrillation, does it matter?	Olsson	FP1920
The DECODE Study	Tuomilehto	FP3826
The ENDEAVOR Stent	Silber	FP760
The Euro Heart Survey of Angina	Daly	FP122
The long-term exposure to air pollution and cardiovascular disease	Rosenlund	FP2068
The Norwegian Vitamin Study (NORVIT)	Bonaa	FP1334
The OASIS 5 Michelangelo programme - Discussant	Califf	FP1333
The praticability of using non-invasive techniques in defining myocardial infarction	Underwood	FP792
The surgeon's perspective	Cotrufo	FP933
Things that go wrong and how to handle them	Elkayam	FP932
Towards the optimal total cardiovascular risk estimation	Giampaoli	FP2727
Treatment patterns in patients with coronary artery disease with and without abnormal glucose regulation	Anselmino	FP1894
Ultrafiltration
Understand cardiovascular disease as a prerequisite	Dimmeler	FP3688
Valvular heart disease	Prendergast	FP3694
Ventricular assist devices	Nanas	FP3653
VF waveform characteristics predict defibrillation success	Koster	FP1294
What is a cryptogenic stroke?	Hennerici	FP2069
Women’s conceptions of their life situation	Stalhammar	FP271